CLINICAL TRIALS PROFILE FOR BRIVARACETAM
✉ Email this page to a colleague
All Clinical Trials for brivaracetam
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00150800 ↗ | This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatmen | Completed | UCB PHARMA Inc. (US) | Phase 3 | 2006-01-01 | This trial, evaluating the long-term safety and tolerability of brivaracetam will provide subjects suffering from epilepsy, who may have benefited from brivaracetam as adjunctive treatment, the opportunity to receive open label brivaracetam treatment. |
NCT00160667 ↗ | A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia) | Completed | UCB Pharma | Phase 2 | 2004-10-11 | Study will assess efficacy, safety and tolerability of brivaracetam in post-herpetic neuralgia (PHN). Duration of 7 weeks divided into 3 periods with no up-titration, nor down-titration. |
NCT00175825 ↗ | A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures. | Completed | UCB Pharma | Phase 2 | 2005-11-07 | This trial will evaluate the efficacy and safety of brivaracetam (at doses of 5, 20 and 50 mg/day in twice a day administration) as add-on therapy in subjects with focal epilepsy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for brivaracetam
Condition Name
Clinical Trial Locations for brivaracetam
Trials by Country
Clinical Trial Progress for brivaracetam
Clinical Trial Phase
Clinical Trial Sponsors for brivaracetam
Sponsor Name